In an effort to curb spending on expensive hospital drugs, Dutch hospitals and insurance companies will launch a pilot project in 2018 to jointly buy cancer drugs. The alliance aims to give payers and providers a stronger position when negotiating prices with pharmaceutical companies, thereby cutting costs. The pilot project will focus on leukemia medications, which cost the Dutch health care system €30 million each year.
